Abstract

Technological and methodological advances in multi-omics data generation and integration approaches help elucidate genetic features of complex biological traits and diseases such as prostate cancer. Due to its heterogeneity, the identification of key functional components involved in the regulation and progression of prostate cancer is a methodological challenge. In this study, we identified key regulatory interactions responsible for primary to metastasis transitions in prostate cancer using network inference approaches by integrating patient derived transcriptomic and miRomics data into gene/miRNA/transcription factor regulatory networks. One such network was derived for each of the clinical states of prostate cancer based on differentially expressed and significantly correlated gene, miRNA and TF pairs from the patient data. We identified key elements of each network using a network analysis approach and validated our results using patient survival analysis. We observed that HOXD10, BCL2 and PGR are the most important factors affected in primary prostate samples, whereas, in the metastatic state, STAT3, JUN and JUNB are playing a central role. Benefiting integrative networks our analysis suggests that some of these molecules were targeted by several overexpressed miRNAs which may have a major effect on the dysregulation of these molecules. For example, in the metastatic tumors five miRNAs (miR-671-5p, miR-665, miR-663, miR-512-3p and miR-371-5p) are mainly responsible for the dysregulation of STAT3 and hence can provide an opportunity for early detection of metastasis and development of alternative therapeutic approaches. Our findings deliver new details on key functional components in prostate cancer progression and provide opportunities for the development of alternative therapeutic approaches.

Highlights

  • Prostate cancer is the second leading cause of cancer death after lung cancer in the United States [1]

  • From the 218 biological samples in the super-series, we found 139 samples with both mRNA and miRNA expression profiles among which 98 samples were taken from primary tumors, 13 from metastatic tumors and 28 from normal prostate tissue

  • For finding differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs) (1) primary prostate tumor samples were compared to normal prostate tissue samples and (2) metastases prostate cancer samples were compared to primary prostate cancer samples

Read more

Summary

Introduction

Prostate cancer is the second leading cause of cancer death after lung cancer in the United States [1]. There are a number of genes involved in prostate cancer progression, which have been reported to be downregulated in some studies and overexpressed in other studies (e.g. STAT3) [2,3]. A large number of studies are based on a reductionist approach to confirm the role of one or another gene or signaling pathway as a key player in prostate cancer metastasis [4,5,6,7,8]. This approach fails to describe the mechanisms of tumor progression and metastasis and the link to clinical phenotypes. Phenotypic outcomes of the disease can be studied using a systems biology approach by modeling the impact of signaling cascade dysregulation on metastasis [9,10]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.